Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Nobuyoshi Sumi"'
Autor:
Motokuni Nakazawa, Yasuyuki Nishiguchi, Takaaki Oka, Masaru Yoshida, Nobuyoshi Sumi, Keiko Wakura, Mutsumi Tarui
Publikováno v:
The Journal of Toxicological Sciences. 22:1-13
Comparative single-dose toxicity studies of (±)-4-diethylamino-1, 1-dimethylbut-2-yn- 1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a new drug for the treatment of urinary frequency and incontinence, were conducte
Autor:
Tsukao Nishimori, Nobuyoshi Sumi, Shigenori Furukawa, Seitaro Ishibashi, Yuzou Taniguchi, Hachiro Kouyama, Keiko Wakura, Mikito Kikumori
Publikováno v:
The Journal of Toxicological Sciences. 22:93-124
Oral single-dose and 13-week repeat-dose toxicity studies of (+/-)-4-ethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride (RCC-36), an active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyc
Autor:
Nobuyoshi Sumi, Yuji Ishikawa, Keiko Iwakura, Hiroshi Shimazu, Yasuyuki Nishiguchi, Masaru Yoshida, Yasuhiro Shindo
Publikováno v:
The Journal of Toxicological Sciences. 21:33-44
Single-dose toxicity studies of prulifloxacin, a new antibacterial agent, were conducted in mice, rats and dogs. In addition, a single-dose toxicity study of (+/-)-6-fluoro-1-methyl-4-oxo-7- (1-piperazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline- 3-carboxy
Autor:
Tagahiko Morinaga, Kimio Yasuhira, Masataka Watanabe, Yasuhiro Shindo, Nobuyoshi Sumi, Shigenori Furukawa, Shigenobu Fujii, Mikito Kikumori
Publikováno v:
The Journal of Toxicological Sciences. 21:187-206
A study of the effect of prulifloxacin, a new antibacterial agent, during the period of organogenesis was conducted in Sprague-Dawley rats. Female rats were given prulifloxacin orally at dose levels of 0 (control), 30, 300, and 3000 mg/kg from day 7
Autor:
Toshio Ihara, Nobuyoshi Sumi, Ryoichi Nagata, Yutaka Chihaya, Asaoka H, Yasuhiro Shindo, Atsushi Akune, Kazuhiro Nakama
Publikováno v:
The Journal of Toxicological Sciences. 21:149-169
Single-dose and repeated dose toxicity studies of prulifloxacin, a new antibacterial agent, were conducted in aged beagle dogs. I. A single-dose toxicity study Prulifloxacin was administered orally to aged female dogs at a single dose of 2500 and 500
Autor:
Keiko Iwakura, Shigeru Ishida, Yasuhiro Shindo, Susumu Yamazaki, Kazutoshi Tamura, Masamichi Iketani, Nobuyoshi Sumi
Publikováno v:
The Journal of Toxicological Sciences. 21:131-148
A repeated dose toxicity study of ( +/- )-6- fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H- [1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid (NM394), the active metabolite of a new antibacterial agent, prulifloxacin, was conducted in Sprague-Dawley rats.
Autor:
Takeharu Tawaratani, Akitaka Kawaminami, Keiko Iwakura, Shinji Matsuyama, Seitaro Ishibashi, Kazuo Kakemi, Takaaki Oka, Yasuhiro Shindo, Nobuyoshi Sumi
Publikováno v:
The Journal of Toxicological Sciences. 21:267-276
Renal toxicity of prulifloxacin, a new antibacterial agent, was investigated in rats of both sexes. The animals were given prulifloxacin orally for 28 days at a dose of 3000 mg/kg. Tubular nephrosis in which crystalline substances appeared primarily
Autor:
Yasuhiro Shindo, Makoto Ando, Keiko Iwakura, Motoyoshi Kojima, Masataka Watanabe, Nobuyoshi Sumi, Yasuhiro Yamashita, Hironobu Tamura
Publikováno v:
The Journal of Toxicological Sciences. 21:241-257
The mutagenicity of prulifloxacin, a new antibacterial agent, was investigated by the reverse mutation test in bacteria, the chromosomal aberration test in cultured cells, and the micronucleus test in mice. In addition, NM394, an active metabolite of
Autor:
Tagahiko Morinaga, Shigenobu Fujii, Kimio Yasuhira, Mikito Kikumori, Yasuhiro Shindo, Masataka Watanabe, Shigenori Furukawa, Nobuyoshi Sumi
Publikováno v:
The Journal of Toxicological Sciences. 21:207-217
A study of the effect of prulifloxacin, a new antibacterial agent, during the period of organogenesis was conducted in New Zealand White rabbits. Female rabbits were given prulifloxacin orally at dose levels of 0 (control), 10, 30 and 100 mg/kg from
Autor:
Katsumasa Ishimura, Nobuyoshi Sumi, Asaoka H, Tatsumi Inoue, Kouhachi Kamata, Yasuhiro Shindo, Mikako Ishihara, Akihiko Ogawa
Publikováno v:
The Journal of Toxicological Sciences. 21:259-265
Photoallergenicity of prulifloxacin, a new antibacterial agent, was examined using guinea pigs compared with those of the other quinolone antibacterial drugs, ofloxacin (OFLX), lomefloxacin (LFLX), ciprofloxacin (CPFX), enoxacin (ENX) and nalidixic a